Cryo-Cell International (OTCMKTS:CCEL) & Mangoceuticals (NASDAQ:MGRX) Financial Review

Cryo-Cell International (OTCMKTS:CCEL – Get Rating) and Mangoceuticals (NASDAQ:MGRX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings.

Earnings and Valuation

This table compares Cryo-Cell International and Mangoceuticals’ gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cryo-Cell International	$30.34 million	1.25	$2.77 million	$0.32	14.33
Mangoceuticals	N/A	N/A	N/A	N/A	N/A

Cryo-Cell International has higher revenue and earnings than Mangoceuticals.

Profitability

This table compares Cryo-Cell International and Mangoceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cryo-Cell International	8.76%	-5,669.11%	4.28%
Mangoceuticals	N/A	N/A	N/A

Insider & Institutional Ownership

8.2% of Cryo-Cell International shares are held by institutional investors. 33.8% of Cryo-Cell International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations for Cryo-Cell International and Mangoceuticals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cryo-Cell International	0	0	1	0	3.00
Mangoceuticals	0	0	0	0	N/A

Cryo-Cell International presently has a consensus price target of $12.00, indicating a potential upside of 161.72%. Given Cryo-Cell International’s higher possible upside, analysts clearly believe Cryo-Cell International is more favorable than Mangoceuticals.

Summary

Cryo-Cell International beats Mangoceuticals on 7 of the 8 factors compared between the two stocks.

About Cryo-Cell International

(Get Rating)

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.

About Mangoceuticals

(Get Rating)

Mangoceuticals Inc. is involved in developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction drug branded `Mango`. Mangoceuticals Inc. is based in DALLAS, TX.